Invention Grant
- Patent Title: Flavivirus NS5A proteins for the treatment of HIV
- Patent Title (中): 用于治疗HIV的黄病毒NS5A蛋白
-
Application No.: US12532064Application Date: 2008-03-20
-
Publication No.: US08268778B2Publication Date: 2012-09-18
- Inventor: James McLinden , Jinhua Xiang , Jack T. Stapleton
- Applicant: James McLinden , Jinhua Xiang , Jack T. Stapleton
- Applicant Address: US IA Iowa City
- Assignee: University of Iowa Research Foundation
- Current Assignee: University of Iowa Research Foundation
- Current Assignee Address: US IA Iowa City
- Agency: Parker Highlander, PLLC
- International Application: PCT/US2008/057719 WO 20080320
- International Announcement: WO2008/127840 WO 20081023
- Main IPC: A01N37/18
- IPC: A01N37/18 ; A61K38/00 ; A61P31/18
Abstract:
GB virus C (GBV-C or hepatitis G virus) is a flavivirus that frequently leads to chronic viremia in humans. The invention provides compositions and methods involving a -GBV-C NS5A peptide or polypeptide for inhibiting and treating HIV infections.
Public/Granted literature
- US20100143454A1 Flavivirus NS5A Proteins For the Treatment of HIV Public/Granted day:2010-06-10
Information query
IPC分类:
